Page last updated: 2024-08-25

voriconazole and Disseminated Fungal Infection

voriconazole has been researched along with Disseminated Fungal Infection in 124 studies

Research

Studies (124)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	63 (50.81)	24.3611
2020's	61 (49.19)	2.80

Authors

Authors	Studies
Hashimoto, K; Kato, I; Kawai, M; Kimura, C; Kondo, N; Maki, H; Mizusawa, E; Naito, A; Nozu, K; Ukai, Y	1
Aguilera, I; Fica, A; Godoy-Martínez, P; Montecinos-Astorga, A; Palma-Fernández, R; Pinar-Pacheco, C	1
Bernards, S; de Boer, MGJ; Hendriks, BJC; Jolink, H; Koopmans, JG; van de Peppel, RJ; van der Beek, MT; van Grootveld, R; van Paassen, J; von dem Borne, PA	1
Arslan, SY; Bal, ZS; Bilen, NM; Ergun, O; Kurugol, Z; Naghiyev, J; Ozarslan, A; Ozenen, GG; Ozkinay, F; Sakul, G	1
DiNardo, CD; DiPippo, AJ; Jiang, Y; Kadia, T; Kontoyiannis, DP; Maiti, A; Montalban-Bravo, G; Rausch, CR; Ravandi, F	1
Belotti, T; Campoli, C; Cojutti, PG; Gatti, M; Masetti, R; Pea, F; Pession, A; Viale, P	1
Carvalhaes, CG; Castanheira, M; DeVries, S; Pfaller, MA; Rhomberg, PR	1
Apfalter, P; Binder, M; Girschikofsky, M; Lass-Flörl, C; Machherndl-Spandl, S; Vockenhuber, T; Weltermann, A	1
Butler-Laporte, G; Ferraro, P; Langevin, MC; Lemieux, C; Luong, ML; Poirier, C; Théorêt, Y	1
Azócar, M; Barraza, M; Coria, P; García, P; Miranda, R; Morales, J; Palma, J; Santolaya, ME; Torres, JP	1
Fisher, BT; Hsu, AJ; Tamma, PD	1
Arce, C; Barraza, M; Flores, D; Ibáñez, C; Santolaya, ME	1
Aram, JA; Cao, G; Cornely, OA; Desai, A; Fayyad, R; Guo, X; Hamed, K; Wu, D; Zhang, J; Zhang, Y	1
Hakki, M; Lewis, JS; Thompson, GR; Wiederhold, NP	1
Li, YH; Su, PX	1
Cai, Y; Chen, A; He, J; Ju, C; Li, S; Lian, Q; Wei, L; Xie, H; Zhao, B; Zhou, S	1
Akashi, K; Izumikawa, K; Kakeya, H; Kamei, K; Kanda, Y; Kimura, SI; Kishida, M; Kohno, S; Matsuda, M; Miyazaki, T; Miyazaki, Y; Mukae, H; Niki, Y; Ogawa, K; Okada, F; Suzuki, J; Takazono, T; Taniguchi, S; Tateda, K; Yoshida, M	1
Bardy, P; Beligaswatte, A; Hahn, U; Hiwase, D; Peake, SL; Roberts, JA; Selby, PR; Shakib, S; Singhal, D; Warner, MS; Yeung, D	1
Arga, G; Çakmakli, HF; Çiftçi, E; Dinçaslan, H; Doğu, F; Ertem, M; Evren, E; Fitöz, S; Haskoloğlu, Ş; İkincioğullari, A; İleri, T; İnce, E; Karahan, ZC; Kendirli, T; Konca, HK; Kuloğlu, Z; Okulu, E; Özdemir, H; Özen, S; Taçyildiz, N; Taşkin, EÇ; Tutar, E; Ünal, E; Us, E	1
Alffenaar, JC; Biemond, BJ; Blijlevens, N; Brüggemann, RJ; de Boer, MGJ; Klein, SK; Kosterink, JGW; Kraemer, D; Minnema, MC; Prakken, NHJ; Rijnders, BJA; Span, LFR; Swen, JJ; van den Heuvel, ER; van der Werf, TS; Veringa, A; Verweij, PE; Wondergem, MJ; Ypma, PF	1
Boyd, S; Mahmoudjafari, Z; Martin, GA; Perry, C; Scott, SA; Thomas, B; Thompson, J	1
Aguado, JM; Aimanianda, V; Armstrong-James, D; Botterel, F; Chen, YC; Husain, S; Lefort, A; Lortholary, O; Melenotte, C; Saliba, F; Slavin, M; Van Delden, C	1
Li, JG; Ma, YS; Xiong, Y; Xue, CB; Ye, QF; Ye, SJ; Zeng, C; Zhou, JY; Zhou, LH; Zhou, W	1
Aram, JA; Engelhardt, M; Hamed, K; Huang, JJ; Kovanda, LL; Yan, J	1
Gautier-Veyret, E; Stanke-Labesque, F; Thiebaut-Bertrand, A	1
Alffenaar, JC; Brüggemann, RJ; Veringa, A	1
Asai, N; Hagihara, M; Hirai, J; Iwamoto, T; Kato, H; Mikamo, H; Mori, N; Umemura, T; Yamagishi, Y	1
Gastine, SE; Groll, AH; Hempel, G; Lehrnbecher, T; Pieper, S; Rauwolf, KK; Tragiannidis, A	1
Salzer, HJF	1
Du, R; Li, Y; Qiu, B; Xing, X; Yang, H	1
Bellissant, E; Boglione-Kerrien, C; Camus, C; Gangneux, JP; Le Bot, A; Lemaitre, F; Marchand, T; Tron, C; Verdier, MC; Zerrouki, S	1
Bharadwaj, B; Paramasivam, S; Raja, K; Rekha, HS	1
Chu, J; Tu, S; Wang, N; Xie, Z; Yang, L; Zhang, K	1
Arnall, J; Avalos, B; Copelan, E; Gerber, J; Ghosh, N; Grunwald, MR; Hamadeh, IS; Hamilton, A; Patel, JN; Plesca, DC; Reese, ES; Robinson, M; Shahid, Z; Steuerwald, N; Symanowski, J; Taylor, M; Trivedi, J	1
Bui, V; Elligsen, M; Kiss, A; Palmay, L; Vyas, A; Walker, SA	1
Arbona-Haddad, E; Bold, TD; Chen, K; Cheng, MP; Cummins, KC; Hammond, SP; Koo, S; Kusztos, AE; Liakos, A; Marty, FM; Orejas, JL; Pandit, A; Solomon, IH	1
Chan, WT; DeFor, TE; Fisher, J; Hage, S; Jennissen, C; Kirstein, MN; Knight-Perry, J; Long, SE; Smith, AR	1
Barbieri, S; Becchetti, C; Burra, P; Cattelan, A; Cillo, U; Feltracco, P; Ferrarese, A; Germani, G; Saluzzo, F; Senzolo, M	1
Chen, H; Cheng, L; Li, Y; Liu, F; Sun, F; Xia, P; Xiang, R; Yao, P	1
Allegra, S; Antonucci, M; Avataneo, V; Cusato, J; D'Avolio, A; De Francia, S; De Nicolò, A; Manca, A	1
Aslam, S; Baddley, J; Burchardt, A; Chen, S; Christner, M; Cornely, OA; Deeren, D; Gräber, S; Heinemann, M; Herbrecht, R; Hoenigl, M; Jenks, JD; Jover Sáenz, A; Kauffman, C; Kemmerling, B; Mehta, SR; Miceli, MH; Pagano, L; Reed, S; Revankar, SG; Seidel, D; Shoham, S; Slavin, MA; Steinmann, J; Taplitz, R; van Hal, S	1
Erbaş, G; Kalkanci, A; Köktürk, N; Özkurt, ZN; Pepeler, MS; Tunçcan, ÖG; Yegin, ZA; Yildirim, Z; Yildiz, Ş	1
He, Q; Kovarik, CL; Miller, DD; Nguyen, CV; Rady, PL; Rubin, N; Tyring, SK	1
Akashi, K; Harada, T; Hayashi, M; Imanaga, H; Kato, K; Kuriyama, T; Miyamoto, T; Mori, Y; Nishida, R; Odawara, J; Takenaka, K; Ueno, T; Yoshimoto, G	1
Chan, SY; Hughes, RM; Neofytos, D; Papanicolaou, G; Perales, MA; Woo, K	1
Cheng, JH; Huang, LP; Jiang, C; Jiang, YK; Que, CX; Wang, RY; Wang, X; Yip, CW; Zhao, HZ; Zhou, LH; Zhu, LP	1
Choi, S; Choi, SH; Chong, YP; Jung, J; Kim, MJ; Kim, SH; Kim, YS; Lee, SO; Son, HJ; Song, JS; Woo, JH	1
Cornu, M; Fichet, C; François, N; Le, V; Leroy, J; Loridant, S; Marceau, L; Sendid, B; Vuotto, F	1
Usayaporn, S; Vanichanan, J; Weeraphon, B	1
Alteri, C; Bielli, A; Brioschi, P; Cairoli, R; Cento, V; Colombo, J; De Gasperi, A; Gasparini, LE; Gatti, M; Lepera, V; Lombardi, G; Mancini, V; Mazza, E; Merli, M; Moioli, MC; Orcese, CA; Perno, CF; Puoti, M; Torri, S; Vismara, C	1
Chen, XJ; Gong, GZ; Jiang, YF; Liang, W; Song, BL; Tang, D; Tian, Y; Wang, F; Wang, WL; Xiang, DX; Xiao, YW; Yan, M; Zhang, BK; Zhang, M; Zhao, YC; Zou, JJ	1
Guarro, J; Pérez-Cantero, A	1
Chuwongwattana, S; Jantararoungtong, T; Medhasi, S; Prommas, S; Puangpetch, A; Sukasem, C	1
Lin, XB; Peng, FH; Wang, F; Xiang, DX; Xiao, YW; Xie, XB; Xu, P; Yan, M; Zhang, BK; Zhao, YC	1
Fujii, S; Hamada, Y; Hanai, Y; Kimura, T; Matsumoto, K; Nishizawa, K; Takahashi, Y; Takesue, Y	1
Álvarez-Uria, A; Barrio-Gutiérrez, JM; Bouza, E; Cuerpo, G; Guinea-Ortega, J; Martínez-Jiménez, MDC; Muñoz, P; Pavone, P; Peligros-Gómez, MI; Valerio, M; Vásquez, V; Vena, A; Zatarain-Nicolás, E	1
Aboutalebian, S; Fakhim, H; Hajiahmadi, S; Hakamifard, A; Hashemi, M; Mohammadi, R	1
Liang, JX; Mu, JS; Wang, YG; Zhang, JC; Zhang, Y; Zhang, YT	1
Aziz, MT; Cruz, OA; Herity, LB	1
Coussement, J; Lindsay, J; Slavin, M; Teh, BW	1
Cervera-Hernandez, ME; Puius, YA; Shuter, J; Szymczak, W	1
Liu, Q; Marks, DI; Slavin, M	1
Hope, WW; Stott, KE	1
Bassetti, M; Bouza, E	1
Denis, J; Herbrecht, R; Ledoux, MP; Toussaint, E	1
Banno, S; Kakizaki, H; Naito, M; Nishimura, K; Ogawa, T; Takahashi, Y; Tanigawa, T; Uchida, Y; Ueda, H; Yamagishi, Y	1
Blot, S; Bulpa, P; Dimopoulos, G; Forêt, F; Frantzeskaki, F; Kosmopoulos, M; Taccone, FS; Van den Abeele, AM; Vogelaers, D	1
Baker, CJ; Brackett, J; Edwards, MS; Foster, CE; Healy, CM; Schady, DA	1
Brazzarola, P; Cazzadori, A; Colato, C; Concia, E; El Dalati, G; Lanzafame, M; Mangani, F; Nicolè, S; Vincenzi, M	1
Assaf, A; Chaftari, AM; Hachem, R; Jiang, Y; Numan, Y; Raad, II; Shah, P	1
Alffenaar, JWC; Brüggemann, RJM; Dekkers, BGJ; Groeneveld, GH; Henriet, SSV; Lashof, AMLO; Muilwijk, EW; Russel, FGM; van de Veerdonk, F; van der Hoeven, J; Verweij, PE; Witjes, B	1
Allegra, S; Carcieri, C; Cusato, J; D'Avolio, A; De Francia, S; De Nicolò, A; Di Perri, G; Fatiguso, G; Favata, F; Pirro, E	1
Aquino, VR; Bergamasco, MD; Castro, PTO; Colombo, AL; Gonçalves, SS; Hagen, F; Martino, MDV; Meis, JF; Negri, CE; Queiroz-Telles, F; Sousa, ACP	1
Alakel, N; Behre, G; Buchheidt, D; Christopeit, M; Cornely, OA; Hasenkamp, J; Kiehl, M; Koldehoff, M; Krause, SW; Lehners, N; Löhnert, AY; Maschmeyer, G; Mayer, K; Mellinghoff, SC; Ostermann, H; Panse, J; Penack, O; Ruhnke, M; Teschner, D; Ullmann, AJ; von Lilienfeld-Toal, M; Wolf, HH	1
Bes, D; Lede, R; Rosanova, MT; Sberna, N; Serrano Aguilar, P	1
Chen, Y; Guo, XB; Jiang, Y; Mao, Q; Yi, XL	1
Chen, L; Feng, Y; Lu, J; Xing, Y; Zhai, Y; Zhou, Y	1
Arwood, MJ; Bulitta, J; Cavallari, LH; Hamadeh, IS; Klinker, KP; Mangal, N; Samant, TS; Schmidt, S	1
Benedetti, E; Campani, D; Di Candio, G; Di Franco, G; Furbetta, N; Guadagni, S; Morelli, L; Mosca, F; Palmeri, M; Petrini, M; Pieroni, E; Tagliaferri, E	1
El Helou, G; Nunez, M; Palavecino, E	1
Lan, GB; Li, ZW; Liang, W; Lin, XB; Peng, FH; Wang, F; Xiang, DX; Xie, XB; Xu, P; Yan, M; Yu, SJ; Zhang, BK	1
Avila, AM; Barba, P; Cho, C; Devlin, S; Huang, YT; Maloy, MA; Montoro, J; Papanicolaou, GA; Perales, MA; Rosillo, C	1
Qiao, M; Qiu, HY; Sun, AN; Tang, L; Tang, XW; Wu, DP; Yang, XF; Zhang, L	1
Ayadi, A; Feki, J; Kammoun, S; Neji, S; Rekik, M; Trabelsi, H	1
Blijlevens, NMA; Brüggemann, RJM; Feuth, T; Kox, M; Pickkers, P; van de Veerdonk, FL; van der Velden, WJFM; Vreugdenhil, B	1
Bacher, A; Klasinc, R; Riesenhuber, M; Willinger, B	1
Anderson, A; Lin, T; McManus, D; Perreault, S; Ruggero, M; Topal, JE	1
Aoun, M; Cornely, OA; Engelhardt, M; Giladi, M; Heinz, WJ; Herbrecht, R; Kaufhold, A; Kovanda, L; Maertens, J; Rahav, G; Saulay, M; Selleslag, D; Ullmann, AJ	1
Ahuja, T; Cirrone, F; Papadopoulos, J; Phillips, K; Siegfried, J	1
Andes, DR; Ghannoum, MA; Hope, WW; Jones, ME; Kovanda, LL; Lademacher, C; Lu, Q; Mukherjee, PK; Santerre Henriksen, A	1
Alizadeh, R; Ardi, P; Daie Ghazvini, R; Dehghan Manshadi, SA; Gatmiri, SM; Gerami Shoar, M; Hashemi, SJ; Hosseinpour, L; Jahanbin, B; Mahmoudi, S; Salehi, M; Zibafar, E	1
Abou-Hanna, H; Basmaciyan, L; Caillot, D; Chrétien, ML; Dalle, F; Gonssaud, B; Lafon, I; Legouge, C; Sautour, M; Valot, S; Verrier, T	1
Bennett, HY; Hayes, RA; O'Hagan, S	1
Capellier, G; Clairet, AL; Lagoutte-Renosi, J; Millon, L; Navellou, JC; Piton, G; Rougny, AC; Winiszewski, H	1
Fang, Y; Gong, Y; Hu, Z; Liu, Y; Shen, J; Tan, J; Wu, G; Zhu, H; Zhu, L	1
Aurbach, U; Caggiano, G; Chander, J; Chedotal, I; Cheng, MP; Cornely, OA; Denis, J; Duarte, RF; Durán Graeff, L; Hamprecht, A; Herbrecht, R; Köhler, P; Lackner, M; Los-Arcos, I; Mares, M; Meißner, A; Mellinghoff, S; Montagna, MT; Pakstis, DL; Piepenbrock, E; Salmanton-García, J; Seidel, D; Slavin, M; Stecher, M; Trauth, J; Vehreschild, JJ; Vehreschild, MJGT; Wisplinghoff, H	1
Bai, YJ; Li, YM; Miao, Q; Shi, YY; Tang, JT; van Gelder, T; Wang, LL; Zou, YG	1
Chen, XJ; Linh Banh, H; Song, BL; Tang, D; Wang, F; Xiang, DX; Xiao, YW; Xu, P; Yan, M; Zhang, BK; Zhang, M; Zhou, HY; Zou, JJ	1
Bagshaw, E; Floros, L; Kuessner, D; Posthumus, J; Sjölin, J	1
Fang, JP; Huang, K; Li, Y; Liao, XY; Qiu, KY; Xu, HG; Zhou, DH	1
Daly, RC; Kennedy, CC; Pennington, KM; Peters, S; Razonable, RR; Scott, JP; Wylam, M	1
Evans, SL; Fish, DN; Kiser, TH; MacLaren, R; Mueller, SW; Van Matre, ET	1
Dehghan Manshadi, SA; Giasvand, F; Jahanbin, B; Khodaveisi, S; Safai Nodeh, SR; Salehi, M; Seifi, A	1
Bao, F; Hu, K; Liu, Y; Qiu, T; Wang, J; Zhang, C	1
Espinoza, N; Farfán, MJ; Galdames, J; Navea, D; Salas, C	1
Cornelissen, JJ; De Kort, E; Lagrou, K; Lestrade, PPA; Maertens, J; Mercier, T; Resendiz-Sharpe, A; Rijnders, BJA; Schauwvlieghe, AFAD; van der Beek, MT; Verweij, PE; von dem Borne, PA	1
Floros, L; Georgallis, M; Pagliuca, A; Rita Capparella, M; Sung, AH; Taie, AA; Weidlich, D	1
Fushimi, K; Imanaka, Y; Komeno, T; Kunisawa, S; Morita, S; Seki, M; Tsutsumi, I; Yoshida, C	1
Andes, DR; Bayless, M; Lepak, AJ; McCreary, EK; Schulz, LT; Van, AP; Wiebe, DA	1
Corcoran, TE; Ensor, CR; Hussain, S; Iasella, CJ; McDyer, JF; Moore, CA; Morrell, MR; Nero, JA; Nguyen, MH; Thanukrishnan, H; Venkataramanan, R	1
Amadori, F; Ciancia, EM; Doria, R; Flammini, S; Gemignani, G; Leonildi, A; Menichetti, F; Sanguinetti, M	1
Chang, SC; Ko, BS; Lee, SH; Sun, HY	1
Bigliardi, S; Candoni, A; Cojutti, P; Fanin, R; Forghieri, F; Isola, M; Luppi, M; Pea, F; Zannier, ME	1
Chen, K; Falcione, BA; Hui, J; Jin, H; Olsen, KM; Tang, H; Wang, T; Zhai, S	1
Kadam, RS; Van Den Anker, JN	1
Al-Dabbagh, M; Groll, AH; Husain, S; Luong, ML; Mitsani, D; Nannya, Y; Racil, Z	1
Chan, Q; Feng, R; Li, C; Liu, Q; Wei, Q; Wu, Y; Xiong, W; Xu, J; Xu, Y; Yan, C	1
Cho, SY; Choi, JH; Choi, JK; Choi, SM; Han, S; Kim, SH; Kwon, JC; Lee, DG; Lee, HJ; Lee, JW; Park, C; Park, SH; Yim, DS; Yoo, JH	1
Hori, D; Kishimoto, K; Kobayashi, K; Kobayashi, R; Sano, H; Suzuki, D; Yasuda, K	1
Chen, L; Dong, H; Dong, Y; Lei, J; Li, Y; Wang, T; Wang, X; Wang, Y; Xie, J; Xing, J; Yang, Q	1
Balch, AH; Constance, JE; Enioutina, EY; Job, KM; Linakis, MW; Liu, X; Olson, J; Rower, JE; Sherwin, CM; Stockmann, C; Thorell, EA; Yu, T	1
Barrueta, JA; Bow, EJ; Charbonneau, C; Cordonnier, C; Cornely, OA; Cragin, L; De Salas-Cansado, M; Garcia-Vidal, C; Jarque, I; Marks, DI; Pagliuca, A; Peral, C; Shaul, AJ; Slavin, M; Solano, C; Sorensen, S; Vanness, DJ	1
Aurbach, U; Cornely, OA; De Hoog, S; Demeter, J; Durán Graeff, L; Hamprecht, A; Kindo, A; Racil, Z; Seidel, D; Vehreschild, MJ; Wisplinghoff, H; Ziegler, M	1
Borgert, SJ; Cavallari, LH; Hamadeh, IS; Hiemenz, JW; Johnson, JA; Klinker, KP; Langaee, TY; Li, W; Mangal, N; Peloquin, CA; Richards, AI; Schmidt, S	1

Reviews

27 review(s) available for voriconazole and Disseminated Fungal Infection

Article	Year
Challenges in the Treatment of Invasive Aspergillosis in Immunocompromised Children. Antimicrobial agents and chemotherapy, 2022, 07-19, Volume: 66, Issue:7 Topics: Antifungal Agents; Aspergillosis; Child; Echinocandins; Humans; Invasive Fungal Infections; Voriconazole	2022
Plain language summary: use of isavuconazole in Chinese patients with an invasive fungal disease. Future microbiology, 2022, Volume: 17 Topics: Antifungal Agents; Aspergillosis; Drug-Related Side Effects and Adverse Reactions; Healthy Volunteers; Humans; Invasive Fungal Infections; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole	2022
New Perspectives on Antimicrobial Agents: Isavuconazole. Antimicrobial agents and chemotherapy, 2022, 09-20, Volume: 66, Issue:9 Topics: Antifungal Agents; Candidiasis, Invasive; Caspofungin; Fungi; Humans; Invasive Fungal Infections; Nitriles; Pyridines; Triazoles; Voriconazole	2022
Invasive aspergillosis in liver transplant recipients. Transplant infectious disease : an official journal of the Transplantation Society, 2023, Volume: 25, Issue:3 Topics: Antifungal Agents; Aspergillosis; Aspergillus; Humans; Invasive Fungal Infections; Liver Transplantation; Transplant Recipients; Voriconazole	2023
A systematic review and meta-analysis of efficacy and safety of isavuconazole for the treatment and prophylaxis of invasive fungal infections. Mycoses, 2023, Volume: 66, Issue:9 Topics: Antifungal Agents; Humans; Invasive Fungal Infections; Triazoles; Voriconazole	2023
[Anti-infective treatment of fungal infections by Candida and Aspergillus]. Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2023, Volume: 118, Issue:6 Topics: Antifungal Agents; Aspergillus; Candida; Candidemia; Candidiasis, Invasive; Humans; Invasive Fungal Infections; Pulmonary Aspergillosis; Voriconazole	2023
Can we predict the influence of inflammation on voriconazole exposure? An overview. The Journal of antimicrobial chemotherapy, 2023, 11-06, Volume: 78, Issue:11 Topics: Adult; Antifungal Agents; Child; Humans; Inflammation; Invasive Fungal Infections; Voriconazole	2023
Geotrichum capitatum Invasive Infection Early After Liver Transplant. Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2020, Volume: 18, Issue:6 Topics: Amphotericin B; Antifungal Agents; Fatal Outcome; Humans; Immunocompromised Host; Immunosuppressive Agents; Invasive Fungal Infections; Liver Transplantation; Male; Middle Aged; Multiple Organ Failure; Opportunistic Infections; Saccharomycetales; Sepsis; Treatment Outcome; Voriconazole	2020
Sarocladium and Acremonium infections: New faces of an old opportunistic fungus. Mycoses, 2020, Volume: 63, Issue:11 Topics: Acremonium; Animals; Antifungal Agents; Arthritis; Blood; Central Nervous System Infections; Dermatomycoses; Drug Resistance, Fungal; Endocarditis; Eye Infections; Humans; Hypocreales; Invasive Fungal Infections; Mycetoma; Mycoses; Onychomycosis; Opportunistic Infections; Osteomyelitis; Peritonitis; Respiratory Tract Infections; Voriconazole	2020
Optimal trough concentration of voriconazole with therapeutic drug monitoring in children: A systematic review and meta-analysis. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2021, Volume: 27, Issue:2 Topics: Antifungal Agents; Child; Drug Monitoring; Humans; Invasive Fungal Infections; Odds Ratio; Voriconazole	2021
Disseminated lomentosporiosis in a heart transplant recipient: Case report and review of the literature. Transplant infectious disease : an official journal of the Transplantation Society, 2021, Volume: 23, Issue:4 Topics: Adult; Antifungal Agents; Heart Transplantation; Humans; Invasive Fungal Infections; Male; Scedosporium; Voriconazole	2021
Choice and duration of antifungal prophylaxis and treatment in high-risk haematology patients. Current opinion in infectious diseases, 2021, 08-01, Volume: 34, Issue:4 Topics: Antifungal Agents; Aspergillosis; Hematology; Humans; Invasive Fungal Infections; Voriconazole	2021
Voriconazole for prophylaxis of invasive fungal infections after allogeneic hematopoietic stem cell transplantation. Expert review of anti-infective therapy, 2017, Volume: 15, Issue:5 Topics: Antifungal Agents; Cost-Benefit Analysis; Drug Administration Schedule; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Practice Guidelines as Topic; Primary Prevention; Transplantation, Homologous; Triazoles; Voriconazole	2017
Therapeutic drug monitoring for invasive mould infections and disease: pharmacokinetic and pharmacodynamic considerations. The Journal of antimicrobial chemotherapy, 2017, 03-01, Volume: 72, Issue:suppl_1 Topics: Antifungal Agents; Biological Availability; Drug Monitoring; Fungi; Humans; Invasive Fungal Infections; Itraconazole; Nitriles; Pyridines; Triazoles; Voriconazole	2017
Invasive mould infections in the ICU setting: complexities and solutions. The Journal of antimicrobial chemotherapy, 2017, 03-01, Volume: 72, Issue:suppl_1 Topics: Antifungal Agents; Aspergillosis; Aspergillus; beta-Glucans; Critical Illness; Galactose; Humans; Immunocompromised Host; Intensive Care Units; Invasive Fungal Infections; Lung Diseases, Fungal; Mannans; Mucor; Mucormycosis; Nitriles; Opportunistic Infections; Pyridines; Respiratory System; Triazoles; Voriconazole	2017
Trichosporonosis in Pediatric Patients With a Hematologic Disorder. Journal of the Pediatric Infectious Diseases Society, 2018, Aug-17, Volume: 7, Issue:3 Topics: Adolescent; Amphotericin B; Antifungal Agents; Child; Drug Therapy, Combination; Echinocandins; Female; Humans; Immunocompromised Host; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Lipopeptides; Male; Micafungin; Neutropenia; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Trichosporonosis; Voriconazole	2018
Successful Antifungal Combination Therapy and Surgical Approach for Aspergillus fumigatus Suppurative Thyroiditis Associated with Thyrotoxicosis and Review of Published Reports. Mycopathologia, 2017, Volume: 182, Issue:9-10 Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Cryoglobulinemia; Drug Therapy, Combination; Echinocandins; Humans; Immunocompromised Host; Invasive Fungal Infections; Lipopeptides; Male; Thyroidectomy; Thyroiditis, Suppurative; Thyrotoxicosis; Treatment Outcome; Voriconazole	2017
Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO). Annals of hematology, 2018, Volume: 97, Issue:2 Topics: Antifungal Agents; Clinical Trials as Topic; Drug Monitoring; Hematology; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Induction Chemotherapy; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Medical Oncology; Myelodysplastic Syndromes; Primary Prevention; Societies, Medical; Triazoles; Voriconazole	2018
Efficacy and safety of voriconazole in immunocompromised patients: systematic review and meta-analysis. Infectious diseases (London, England), 2018, Volume: 50, Issue:7 Topics: Adolescent; Antifungal Agents; Child; Drug-Related Side Effects and Adverse Reactions; Humans; Immunocompromised Host; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Randomized Controlled Trials as Topic; Voriconazole; Young Adult	2018
Meta-analysis of the safety of voriconazole in definitive, empirical, and prophylactic therapies for invasive fungal infections. BMC infectious diseases, 2017, 12-28, Volume: 17, Issue:1 Topics: Antifungal Agents; Databases, Factual; Drug Tolerance; Humans; Invasive Fungal Infections; Kidney Diseases; Liver Diseases; Odds Ratio; Voriconazole	2017
Multiple small bowel perforations due to invasive aspergillosis in a patient with acute myeloid leukemia: case report and a systematic review of the literature. Infection, 2018, Volume: 46, Issue:3 Topics: Adult; Antifungal Agents; Aspergillosis; Humans; Immunocompromised Host; Intestinal Perforation; Intestine, Small; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Neutropenia; Treatment Outcome; Voriconazole	2018
Invasive Fungal Infection Caused by Exophiala dermatitidis in a Patient After Lung Transplantation: Case Report and Literature Review. Mycopathologia, 2019, Volume: 184, Issue:1 Topics: Aged; Antifungal Agents; DNA, Fungal; DNA, Ribosomal Spacer; Exophiala; Fatal Outcome; Humans; Immunocompromised Host; Invasive Fungal Infections; Lung Transplantation; Male; Microbial Sensitivity Tests; Phaeohyphomycosis; Sequence Analysis, DNA; Surgical Wound Infection; Voriconazole	2019
A suppurative thyroiditis and perineal subcutaneous abscess related with aspergillus fumigatus: a case report and literature review. BMC infectious diseases, 2018, Dec-27, Volume: 18, Issue:1 Topics: Abscess; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Dermatomycoses; Female; Humans; Immunocompromised Host; Invasive Fungal Infections; Lupus Erythematosus, Systemic; Middle Aged; Perineum; Suction; Thyroiditis, Suppurative; Voriconazole	2018
Trough concentration of voriconazole and its relationship with efficacy and safety: a systematic review and meta-analysis. The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:7 Topics: Antifungal Agents; Drug Monitoring; Humans; Invasive Fungal Infections; Liver; Mycoses; Nervous System; Treatment Outcome; Voriconazole	2016
Pediatric Clinical Pharmacology of Voriconazole: Role of Pharmacokinetic/Pharmacodynamic Modeling in Pharmacotherapy. Clinical pharmacokinetics, 2016, Volume: 55, Issue:9 Topics: Adolescent; Adult; Antifungal Agents; Aspergillus; Candida; Child; Child, Preschool; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Monitoring; Female; Genotype; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Invasive Fungal Infections; Male; Middle Aged; Models, Biological; Pharmacology, Clinical; Retrospective Studies; Voriconazole; Young Adult	2016
Utility of voriconazole therapeutic drug monitoring: a meta-analysis. The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:7 Topics: Antifungal Agents; Drug Monitoring; Humans; Invasive Fungal Infections; Mycoses; Treatment Outcome; Voriconazole	2016
Pharmacodynamic studies of voriconazole: informing the clinical management of invasive fungal infections. Expert review of anti-infective therapy, 2016, Volume: 14, Issue:8 Topics: Antifungal Agents; Area Under Curve; Dose-Response Relationship, Drug; Genetic Predisposition to Disease; Humans; Invasive Fungal Infections; Microbial Sensitivity Tests; Models, Biological; Voriconazole	2016

Trials

8 trial(s) available for voriconazole and Disseminated Fungal Infection

Article	Year
Efficacy and safety of isavuconazole against deep-seated mycoses: A phase 3, randomized, open-label study in Japan. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2023, Volume: 29, Issue:2 Topics: Antifungal Agents; Aspergillosis; Cryptococcosis; Humans; Invasive Fungal Infections; Japan; Mucormycosis; Pulmonary Aspergillosis; Triazoles; Voriconazole	2023
Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients: a multicentre, prospective, cluster randomised, crossover clinical trial. International journal of antimicrobial agents, 2023, Volume: 61, Issue:2 Topics: Adolescent; Adult; Antifungal Agents; Aspergillosis; Drug Monitoring; Humans; Invasive Fungal Infections; Prospective Studies; Retrospective Studies; Voriconazole	2023
Comment on 'Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients: A multicentre, prospective, cluster randomised, crossover clinical trial'. International journal of antimicrobial agents, 2023, Volume: 62, Issue:2 Topics: Antifungal Agents; Aspergillosis; Drug Monitoring; Humans; Invasive Fungal Infections; Prospective Studies; Voriconazole	2023
In reply to comment on 'Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients: a multicenter, prospective, cluster randomised, crossover clinical trial'. International journal of antimicrobial agents, 2023, Volume: 62, Issue:2 Topics: Antifungal Agents; Aspergillosis; Drug Monitoring; Humans; Invasive Fungal Infections; Prospective Studies; Voriconazole	2023
A phase I dose finding study of intravenous voriconazole in pediatric patients undergoing hematopoietic cell transplantation. Bone marrow transplantation, 2020, Volume: 55, Issue:5 Topics: Administration, Intravenous; Antifungal Agents; Child; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Voriconazole	2020
Population pharmacokinetics of voriconazole and CYP2C19 polymorphisms for optimizing dosing regimens in renal transplant recipients. British journal of clinical pharmacology, 2018, Volume: 84, Issue:7 Topics: Administration, Oral; Adult; Antifungal Agents; Biological Availability; Biological Variation, Population; Body Weight; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Female; Genotype; Graft Rejection; Humans; Immunosuppressive Agents; Intestinal Absorption; Invasive Fungal Infections; Kidney Transplantation; Male; Middle Aged; Models, Biological; Polymorphism, Single Nucleotide; Postoperative Period; Prospective Studies; Time Factors; Transplant Recipients; Voriconazole; Young Adult	2018
Treatment outcomes in patients with proven/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazole. Mycoses, 2018, Volume: 61, Issue:11 Topics: Adult; Aged; Antifungal Agents; Female; Fungi; Humans; Invasive Fungal Infections; Male; Middle Aged; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole	2018
Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:1 Topics: Antifungal Agents; Aspergillosis; Aspergillus; Humans; Invasive Fungal Infections; Microbial Sensitivity Tests; Nitriles; Pyridines; Triazoles; Voriconazole	2019

Other Studies

89 other study(ies) available for voriconazole and Disseminated Fungal Infection

Article	Year
Identification of Thiazoyl Guanidine Derivatives as Novel Antifungal Agents Inhibiting Ergosterol Biosynthesis for Treatment of Invasive Fungal Infections. Journal of medicinal chemistry, 2021, 07-22, Volume: 64, Issue:14 Topics: Antifungal Agents; Aspergillus fumigatus; Dose-Response Relationship, Drug; Ergosterol; Guanidine; Humans; Invasive Fungal Infections; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Thiazoles	2021
[Invasive ocular fungal infection by Scedosporium apiospermum in an immunocompromised patient]. Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia, 2021, Volume: 38, Issue:4 Topics: Aged; Antifungal Agents; Eye Infections, Fungal; Female; Humans; Immunocompromised Host; Invasive Fungal Infections; Scedosporium; Voriconazole	2021
Implementation of a clinical decision rule for selecting empiric treatment for invasive aspergillosis in a setting with high triazole resistance. Medical mycology, 2021, Dec-08, Volume: 60, Issue:1 Topics: Animals; Antifungal Agents; Aspergillosis; Clinical Decision Rules; Invasive Fungal Infections; Triazoles; Voriconazole	2021
Successful treatment of hepatic and mesh Aspergillosis in a neonate with giant omphalocele. Journal de mycologie medicale, 2022, Volume: 32, Issue:2 Topics: Antifungal Agents; Aspergillosis; Aspergillus flavus; Child; Hernia, Umbilical; Humans; Infant, Newborn; Invasive Fungal Infections; Male; Surgical Mesh; Voriconazole	2022
Comparison of Mold Active Triazoles as Primary Antifungal Prophylaxis in Patients With Newly Diagnosed Acute Myeloid Leukemia in the Era of Molecularly Targeted Therapies. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 10-29, Volume: 75, Issue:9 Topics: Adult; Antifungal Agents; Azoles; Chemical and Drug Induced Liver Injury; Echinocandins; Fungi; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Molecular Targeted Therapy; Retrospective Studies; Triazoles; Voriconazole	2022
Real-World Comparison of Isavuconazole and Voriconazole in Terms of the Need for Dosage Adjustments Guided by Clinical Pharmacological Advice During Primary Prophylaxis of Invasive Fungal Infections in Pediatric Patients with Hemato-Oncological Malignanci Therapeutic drug monitoring, 2022, 10-01, Volume: 44, Issue:5 Topics: Antifungal Agents; Azoles; Child; Humans; Invasive Fungal Infections; Neoplasms; Nitriles; Pyridines; Retrospective Studies; Triazoles; Voriconazole	2022
Impact of COVID-19 on the antifungal susceptibility profiles of isolates collected in a global surveillance program that monitors invasive fungal infections. Medical mycology, 2022, May-06, Volume: 60, Issue:5 Topics: Animals; Antifungal Agents; Candida glabrata; Candida parapsilosis; Candida tropicalis; COVID-19; Drug Resistance, Fungal; Fluconazole; Invasive Fungal Infections; Microbial Sensitivity Tests; Pandemics; Voriconazole	2022
Efficacy and safety of voriconazole as invasive fungal infection prophylaxis in patients with acute myeloid leukemia. Leukemia & lymphoma, 2022, Volume: 63, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Middle Aged; Retrospective Studies; Voriconazole; Young Adult	2022
Voriconazole therapeutic drug monitoring among lung transplant recipients receiving targeted therapy for invasive aspergillosis. Clinical transplantation, 2022, Volume: 36, Issue:8 Topics: Antifungal Agents; Aspergillosis; Drug Monitoring; Humans; Invasive Fungal Infections; Lung; Retrospective Studies; Transplant Recipients; Voriconazole	2022
[Evaluation dosing intravenous voriconazole three times a day vs twice daily for the treatment of invasive aspergillosis in immunocompromised children: therapeutic drugs monitoring and safety]. Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia, 2022, Volume: 39, Issue:1 Topics: Antifungal Agents; Aspergillosis; Child; Humans; Invasive Fungal Infections; Pharmaceutical Preparations; Voriconazole	2022
[Voriconazole monitorization in pediatric patients, difficulties in dose adjustment]. Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia, 2022, Volume: 39, Issue:2 Topics: Antifungal Agents; Child; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Retrospective Studies; Voriconazole	2022
[Value of the Diagnostic-Driven Therapy with Voriconazole in Patients with Hematological Disorders Complicated by Invasive Fungal Disease]. Zhongguo shi yan xue ye xue za zhi, 2022, Volume: 30, Issue:4 Topics: Antifungal Agents; Hematologic Diseases; Humans; Invasive Fungal Infections; Retrospective Studies; Voriconazole	2022
Antifungal prophylactic effectiveness and intrapulmonary concentrations of voriconazole versus posaconazole in lung transplant recipients. Medical mycology, 2022, Sep-02, Volume: 60, Issue:9 Topics: Animals; Antifungal Agents; Humans; Invasive Fungal Infections; Lung; Retrospective Studies; Transplant Recipients; Triazoles; Voriconazole	2022
Optimizing antifungal prophylaxis in allogeneic stem cell transplantation: A cohort study of two different approaches. Transplant infectious disease : an official journal of the Transplantation Society, 2022, Volume: 24, Issue:6 Topics: Antifungal Agents; Cohort Studies; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Retrospective Studies; Voriconazole	2022
Pediatric Invasive Aspergillosis: a Retrospective Review of 59 Cases. Japanese journal of infectious diseases, 2023, Mar-24, Volume: 76, Issue:2 Topics: Antifungal Agents; Aspergillosis; Child; Female; Humans; Invasive Fungal Infections; Male; Retrospective Studies; Voriconazole	2023
Incidence of breakthrough fungal infections on isavuconazole prophylaxis compared to posaconazole and voriconazole. Transplant infectious disease : an official journal of the Transplantation Society, 2023, Volume: 25, Issue:2 Topics: Antifungal Agents; Female; Humans; Incidence; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Mycoses; Prospective Studies; Retrospective Studies; Voriconazole	2023
Donor-Derived Transmission of Scedosporiosis in Kidney Transplant Recipients from a Systemic lupus erythematosus donor. Current medical science, 2023, Volume: 43, Issue:2 Topics: Humans; Invasive Fungal Infections; Kidney Transplantation; Lupus Erythematosus, Systemic; Voriconazole	2023
Post-hoc analysis of the safety and efficacy of isavuconazole in older patients with invasive fungal disease from the VITAL and SECURE studies. Scientific reports, 2023, 04-25, Volume: 13, Issue:1 Topics: Aged; Antifungal Agents; Aspergillosis; Humans; Invasive Fungal Infections; Nitriles; Prospective Studies; Triazoles; Voriconazole	2023
Voriconazole plasma concentrations and dosing in paediatric patients below 24 months of age. Mycoses, 2023, Volume: 66, Issue:11 Topics: Antifungal Agents; Child; Humans; Immunocompromised Host; Infant; Invasive Fungal Infections; Retrospective Studies; Voriconazole	2023
Efficacy and influencing factor analysis of Voriconazole in the treatment of invasive fungal infections. Diagnostic microbiology and infectious disease, 2023, Volume: 107, Issue:3 Topics: Antifungal Agents; Drug Monitoring; Humans; Invasive Fungal Infections; Treatment Outcome; Voriconazole	2023
Voriconazole-induced psychosis in rhino-orbital invasive aspergillosis. BMJ case reports, 2023, Oct-11, Volume: 16, Issue:10 Topics: Antifungal Agents; Aspergillosis; Humans; Invasive Fungal Infections; Male; Psychotic Disorders; Pyrimidines; Voriconazole	2023
Comparative study of posaconazole and voriconazole for primary antifungal prophylaxis in patients with pediatric acute leukemia. Scientific reports, 2023, 11-01, Volume: 13, Issue:1 Topics: Antifungal Agents; Child; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Retrospective Studies; Triazoles; Voriconazole	2023
Evaluation of CYP2C19 Genotype-Guided Voriconazole Prophylaxis After Allogeneic Hematopoietic Cell Transplant. Clinical pharmacology and therapeutics, 2020, Volume: 107, Issue:3 Topics: Adult; Aged; Antifungal Agents; Cost Savings; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Female; Genotype; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Male; Middle Aged; Prospective Studies; Voriconazole	2020
Voriconazole prophylaxis in leukemic patients: A retrospective single-center study. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2020, Volume: 26, Issue:4 Topics: Adolescent; Adult; Aged; Antifungal Agents; Female; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Retrospective Studies; Voriconazole; Young Adult	2020
Use of triazoles for the treatment of invasive aspergillosis: A three-year cohort analysis. Mycoses, 2020, Volume: 63, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Cohort Studies; Female; Humans; Invasive Fungal Infections; Male; Middle Aged; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole	2020
Therapeutic drug monitoring and safety of voriconazole in elderly patients. International immunopharmacology, 2020, Volume: 78 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Aging; Antifungal Agents; Aspergillosis; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Inflammation; Infusions, Intravenous; Invasive Fungal Infections; Male; Middle Aged; Procalcitonin; Retrospective Studies; Voriconazole	2020
Effect of Gender and Age on Voriconazole Trough Concentrations in Italian Adult Patients. European journal of drug metabolism and pharmacokinetics, 2020, Volume: 45, Issue:3 Topics: Adult; Age Factors; Aged; Antifungal Agents; Body Mass Index; Chromatography, High Pressure Liquid; Cohort Studies; Creatinine; Dose-Response Relationship, Drug; Female; Humans; Invasive Fungal Infections; Italy; Male; Middle Aged; Retrospective Studies; Sex Factors; Voriconazole	2020
Voriconazole plus terbinafine combination antifungal therapy for invasive Lomentospora prolificans infections: analysis of 41 patients from the FungiScope® registry 2008-2019. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2020, Volume: 26, Issue:6 Topics: Adult; Aged; Antifungal Agents; Drug Therapy, Combination; Female; Humans; Invasive Fungal Infections; Male; Microbial Sensitivity Tests; Middle Aged; Registries; Retrospective Studies; Scedosporium; Terbinafine; Treatment Outcome; Voriconazole	2020
Secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients with invasive fungal infection. Journal of infection in developing countries, 2018, 09-30, Volume: 12, Issue:9 Topics: Adolescent; Adult; Allografts; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Female; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole; Young Adult	2018
Presence of human papillomavirus DNA in voriconazole-associated cutaneous squamous cell carcinoma. International journal of dermatology, 2020, Volume: 59, Issue:5 Topics: Aged; Betapapillomavirus; Carcinoma, Squamous Cell; DNA, Viral; Female; Graft Rejection; Humans; Immunocompromised Host; Immunosuppressive Agents; Invasive Fungal Infections; Male; Middle Aged; Organ Transplantation; Papillomavirus Infections; Polymerase Chain Reaction; Retrospective Studies; Skin Neoplasms; Voriconazole	2020
Successful allogeneic stem cell transplantation in a case with acute myeloid leukemia and invasive Schizophyllum commune rhinosinusitis. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2020, Volume: 26, Issue:5 Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Female; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Middle Aged; Molecular Diagnostic Techniques; Rhinitis; Schizophyllum; Sinusitis; Transplantation, Homologous; Treatment Outcome; Voriconazole	2020
Reasons for voriconazole prophylaxis discontinuation in allogeneic hematopoietic cell transplant recipients: A real-life paradigm. Medical mycology, 2020, Nov-10, Volume: 58, Issue:8 Topics: Adult; Antibiotic Prophylaxis; Antifungal Agents; Chemical and Drug Induced Liver Injury; Female; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Male; Middle Aged; Retrospective Studies; Risk Factors; Transplant Recipients; Transplantation, Homologous; Treatment Outcome; Voriconazole	2020
Genetic polymorphisms of transient receptor potential melastatin 1 correlate with voriconazole-related visual adverse events. Mycoses, 2020, Volume: 63, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Female; Genotype; Hallucinations; Humans; Invasive Fungal Infections; Male; Middle Aged; Polymorphism, Single Nucleotide; Prospective Studies; TRPM Cation Channels; Voriconazole; Young Adult	2020
Risk factors for mortality in patients with pulmonary mucormycosis. Mycoses, 2020, Volume: 63, Issue:7 Topics: Aged; Antifungal Agents; Female; Hospital Mortality; Humans; Immunocompromised Host; Invasive Fungal Infections; Male; Middle Aged; Mucormycosis; Neutropenia; Pneumonia; Retrospective Studies; Risk Factors; Seoul; Tertiary Care Centers; Voriconazole	2020
Invasive rhino-orbital-cerebral aspergillosis in an immunocompetent patient. Journal de mycologie medicale, 2020, Volume: 30, Issue:3 Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Blindness; Central Nervous System Fungal Infections; Diabetes Complications; Eye Infections, Fungal; Humans; Immunocompetence; Invasive Fungal Infections; Male; Middle Aged; Neuroaspergillosis; Orbital Diseases; Rhinitis; Voriconazole	2020
Successful challenge of voriconazole in a patient with posaconazole-associated minor drug eruption: A case report. Journal of clinical pharmacy and therapeutics, 2020, Volume: 45, Issue:6 Topics: Adult; Antifungal Agents; Diagnosis, Differential; Drug Eruptions; Female; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Triazoles; Voriconazole	2020
Quantification of 1,3-β-d-glucan by Wako β-glucan assay for rapid exclusion of invasive fungal infections in critical patients: A diagnostic test accuracy study. Mycoses, 2020, Volume: 63, Issue:12 Topics: Aged; Antifungal Agents; beta-Glucans; Caspofungin; Diagnostic Tests, Routine; Female; Fluconazole; Humans; Intensive Care Units; Invasive Fungal Infections; Limit of Detection; Male; Middle Aged; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity; Voriconazole	2020
Population pharmacokinetics, safety and dosing optimization of voriconazole in patients with liver dysfunction: A prospective observational study. British journal of clinical pharmacology, 2021, Volume: 87, Issue:4 Topics: Antifungal Agents; Humans; Invasive Fungal Infections; Liver Diseases; Prospective Studies; Voriconazole	2021
Impact of CYP2C19, CYP3A4, ABCB1, and FMO3 genotypes on plasma voriconazole in Thai patients with invasive fungal infections. Pharmacology research & perspectives, 2020, Volume: 8, Issue:6 Topics: Adolescent; Adult; Aged; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B; Child; Child, Preschool; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Female; Genotype; Humans; Invasive Fungal Infections; Male; Middle Aged; Oxygenases; Retrospective Studies; Thailand; Voriconazole; Young Adult	2020
Predictors of Adverse Events and Determinants of the Voriconazole Trough Concentration in Kidney Transplantation Recipients. Clinical and translational science, 2021, Volume: 14, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Antifungal Agents; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hemoglobins; Humans; Invasive Fungal Infections; Kidney Transplantation; Male; Pharmacogenomic Variants; Platelet Count; Prospective Studies; Voriconazole	2021
Fatal disseminated aspergillosis in an immunocompetent patient with COVID-19 due to Aspergillus ochraceus. Journal de mycologie medicale, 2021, Volume: 31, Issue:2 Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus ochraceus; Biomarkers; Brain Abscess; Bronchoalveolar Lavage Fluid; COVID-19; COVID-19 Nucleic Acid Testing; Fatal Outcome; Galactose; Humans; Immunocompetence; Invasive Fungal Infections; Lung Diseases, Fungal; Male; Mannans; SARS-CoV-2; Voriconazole	2021
[The application of Voriconazole in 76 patients with cirrhosis at Child-Pugh C stage complicated by invasive fungal infection]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2021, Feb-20, Volume: 29, Issue:2 Topics: Antifungal Agents; Humans; Invasive Fungal Infections; Liver Cirrhosis; Retrospective Studies; Voriconazole	2021
Evaluation of a primary antifungal prophylaxis protocol for preventing invasive mold infections after allogeneic hematopoietic stem cell transplantation. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2022, Volume: 28, Issue:4 Topics: Adult; Antifungal Agents; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Retrospective Studies; Voriconazole	2022
Lung, Brain, and Spinal Cord Abscesses After a Near-Drowning Episode. The American journal of medicine, 2021, Volume: 134, Issue:11 Topics: Abscess; Adult; Antifungal Agents; beta-Glucans; Brain Abscess; Central Nervous System Infections; Dexamethasone; Fresh Water; Humans; Invasive Fungal Infections; Lung Abscess; Magnetic Resonance Imaging; Male; Micafungin; Near Drowning; Pneumonia, Aspiration; Scedosporium; Spinal Cord Diseases; Tomography, X-Ray Computed; Voriconazole	2021
New pharmacological opportunities for the treatment of invasive mould diseases. The Journal of antimicrobial chemotherapy, 2017, 03-01, Volume: 72, Issue:suppl_1 Topics: Amphotericin B; Anidulafungin; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Echinocandins; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Pyridines; Triazoles; Voriconazole	2017
Advanced surgical technique for invasive fungal sinusitis: endoscopic orbit-sinus combined approach. Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy, 2017, Volume: 26, Issue:5 Topics: Aged, 80 and over; Antifungal Agents; Aspergillosis; Endoscopy; Ethmoid Sinus; Ethmoid Sinusitis; Female; Humans; Invasive Fungal Infections; Male; Maxillary Sinus; Maxillary Sinusitis; Middle Aged; Nasal Cavity; Orbit; Voriconazole	2017
Endomyocardial and pericardial aspergillosis in critically ill patients. Mycoses, 2017, Volume: 60, Issue:9 Topics: Amphotericin B; Antifungal Agents; Caspofungin; Critical Illness; Echinocandins; Female; Heart Diseases; Humans; Immunocompetence; Immunocompromised Host; Incidence; Invasive Fungal Infections; Lipopeptides; Male; Middle Aged; Myocardium; Pericardium; Risk Factors; Voriconazole	2017
Comparing the safety and efficacy of voriconazole versus posaconazole in the prevention of invasive fungal infections in high-risk patients with hematological malignancies. International journal of antimicrobial agents, 2017, Volume: 50, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Chemoprevention; Drug-Related Side Effects and Adverse Reactions; Female; Hematologic Neoplasms; Hospitals, University; Humans; Invasive Fungal Infections; Male; Middle Aged; Retrospective Studies; Survival Analysis; Texas; Treatment Outcome; Triazoles; Voriconazole; Young Adult	2017
Flucloxacillin Results in Suboptimal Plasma Voriconazole Concentrations. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:9 Topics: Adolescent; Adult; Aged; Antifungal Agents; Aspergillus; Child; Child, Preschool; Drug Interactions; Female; Floxacillin; Granulomatous Disease, Chronic; Humans; Invasive Fungal Infections; Male; Middle Aged; Pulmonary Aspergillosis; Voriconazole; Young Adult	2017
Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children. British journal of clinical pharmacology, 2018, Volume: 84, Issue:1 Topics: Administration, Intravenous; Administration, Oral; Adolescent; Age Factors; Antifungal Agents; Biological Variation, Population; Child; Child, Preschool; Chromatography, High Pressure Liquid; Creatinine; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Invasive Fungal Infections; Male; Mass Spectrometry; Sex Factors; Voriconazole	2018
Triazole Resistance Is Still Not Emerging in Aspergillus fumigatus Isolates Causing Invasive Aspergillosis in Brazilian Patients. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:11 Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brazil; Drug Resistance, Fungal; Humans; Invasive Fungal Infections; Itraconazole; Microbial Sensitivity Tests; Retrospective Studies; Voriconazole	2017
[Treatment of Invasive Fungal Infection in Childhood Acute Lymphoblastic Leukemia with Amphotericin B and Voriconazole]. Zhongguo shi yan xue ye xue za zhi, 2017, Volume: 25, Issue:6 Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Child; Humans; Invasive Fungal Infections; Mycoses; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Voriconazole	2017
Optimization of Voriconazole Therapy for the Treatment of Invasive Fungal Infections in Adults. Clinical pharmacology and therapeutics, 2018, Volume: 104, Issue:5 Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Cytochrome P-450 CYP2C19; Drug Dosage Calculations; Drug Interactions; Drug Monitoring; Female; Genotype; Humans; Invasive Fungal Infections; Male; Microbial Sensitivity Tests; Middle Aged; Models, Biological; Pantoprazole; Pharmacogenomic Variants; Phenotype; Proton Pump Inhibitors; Risk Assessment; Voriconazole	2018
Double invasive fungal infection due to dematiaceous moulds in a renal transplant patient. BMJ case reports, 2018, Feb-08, Volume: 2018 Topics: Alternaria; Alternariosis; Amphotericin B; Antifungal Agents; Ascomycota; Fatal Outcome; Humans; Immunocompromised Host; Invasive Fungal Infections; Kidney Transplantation; Knee; Lung Diseases, Fungal; Male; Middle Aged; Pneumonia; Risk Factors; Voriconazole	2018
Sequential systematic anti-mold prophylaxis with micafungin and voriconazole results in very low incidence of invasive mold infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Transplant infectious disease : an official journal of the Transplantation Society, 2018, Volume: 20, Issue:4 Topics: Adult; Aged; Antibiotic Prophylaxis; Antifungal Agents; Echinocandins; Female; Fungi; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Invasive Fungal Infections; Lipopeptides; Male; Micafungin; Middle Aged; Retrospective Studies; Transplantation, Homologous; Treatment Outcome; Voriconazole; Young Adult	2018
Posaconazole vs. voriconazole in the prevention of invasive fungal diseases in patients with haematological malignancies: A retrospective study. Journal de mycologie medicale, 2018, Volume: 28, Issue:2 Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; China; Cost-Benefit Analysis; Female; Fluconazole; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Itraconazole; Male; Middle Aged; Retrospective Studies; Triazoles; Voriconazole; Young Adult	2018
Orbital cellulitis secondary to a fungal sinusitis caused by Scopulariopsis: The first case in Tunisia. Journal de mycologie medicale, 2018, Volume: 28, Issue:2 Topics: Debridement; Humans; Invasive Fungal Infections; Magnetic Resonance Imaging; Male; Middle Aged; Orbital Cellulitis; Scopulariopsis; Sinusitis; Tomography, X-Ray Computed; Tunisia; Voriconazole	2018
Moderate correlation between systemic IL-6 responses and CRP with trough concentrations of voriconazole. British journal of clinical pharmacology, 2018, Volume: 84, Issue:9 Topics: Antifungal Agents; Biological Variation, Population; C-Reactive Protein; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Inflammation; Interleukin-6; Interleukin-8; Invasive Fungal Infections; Male; Middle Aged; Models, Biological; Prospective Studies; Retrospective Studies; Voriconazole	2018
Evaluating a voriconazole dose modification guideline to optimize dosing in patients with hematologic malignancies. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2019, Volume: 25, Issue:6 Topics: Adult; Age Factors; Aged; Antifungal Agents; Body Mass Index; Female; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Male; Middle Aged; Practice Guidelines as Topic; Prospective Studies; Voriconazole; Young Adult	2019
Posaconazole versus voriconazole as antifungal prophylaxis during induction therapy for acute myelogenous leukemia or myelodysplastic syndrome. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2019, Volume: 25, Issue:2 Topics: Adult; Aged; Antifungal Agents; Female; Humans; Induction Chemotherapy; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Retrospective Studies; Triazoles; Voriconazole	2019
First report of invasive pulmonary infection by Didymella microchlamydospora and successful treatment with voriconazole. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2019, Volume: 25, Issue:3 Topics: Antifungal Agents; Biopsy; Bronchi; Coelomomyces; Humans; Invasive Fungal Infections; Lung Diseases, Fungal; Male; Middle Aged; Thorax; Tomography, X-Ray Computed; Treatment Outcome; Voriconazole	2019
First case of proven invasive pulmonary infection due to Trichoderma longibrachiatum in a neutropenic patient with acute leukemia. Journal de mycologie medicale, 2018, Volume: 28, Issue:4 Topics: Aged; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Humans; Immunocompromised Host; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Lung; Lung Diseases, Fungal; Male; Treatment Outcome; Trichoderma; Voriconazole	2018
First two cases of Exserohilum rostratum keratitis in Australia. Clinical & experimental ophthalmology, 2019, Volume: 47, Issue:5 Topics: Adult; Antifungal Agents; Ascomycota; Australia; Ciprofloxacin; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Female; Humans; Invasive Fungal Infections; Male; Middle Aged; Natamycin; Voriconazole	2019
The pharmacokinetic challenge of treating invasive aspergillosis complicating severe influenzae assisted by extracorporeal membrane oxygenation. Critical care (London, England), 2018, 12-22, Volume: 22, Issue:1 Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bronchopulmonary Sequestration; Extracorporeal Membrane Oxygenation; Humans; Influenza, Human; Invasive Fungal Infections; Male; Middle Aged; Nitriles; Pyridines; Triazoles; Voriconazole	2018
Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope Critical reviews in microbiology, 2019, Volume: 45, Issue:1 Topics: Adult; Aged; Antifungal Agents; Female; Humans; Immunocompromised Host; Invasive Fungal Infections; Male; Middle Aged; Neoplasms; Organ Transplantation; Prognosis; Risk Factors; Scedosporium; Survival Analysis; Treatment Outcome; Voriconazole	2019
Correlation of CYP2C19 genotype with plasma voriconazole exposure in South-western Chinese Han patients with invasive fungal infections. Medicine, 2019, Volume: 98, Issue:3 Topics: Adult; Alleles; Antifungal Agents; Asian People; Cohort Studies; Cytochrome P-450 CYP2C19; Drug Monitoring; Female; Genotype; Humans; Invasive Fungal Infections; Male; Middle Aged; Pharmacogenomic Testing; Phenotype; Polymorphism, Genetic; Retrospective Studies; Voriconazole	2019
Identifying factors affecting the pharmacokinetics of voriconazole in patients with liver dysfunction: A population pharmacokinetic approach. Basic & clinical pharmacology & toxicology, 2019, Volume: 125, Issue:1 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Biological Availability; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Invasive Fungal Infections; Liver; Liver Diseases; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Retrospective Studies; Voriconazole	2019
Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden. BMC infectious diseases, 2019, Feb-11, Volume: 19, Issue:1 Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Case-Control Studies; Cost-Benefit Analysis; Decision Trees; Female; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Pyridines; Quality-Adjusted Life Years; Sweden; Triazoles; Voriconazole	2019
Combination antifungal treatment for invasive fungal disease after hematopoietic stem cell transplantation in children with hematological disorders. Transplant infectious disease : an official journal of the Transplantation Society, 2019, Volume: 21, Issue:3 Topics: Adolescent; Amphotericin B; Antifungal Agents; Caspofungin; Child; Child, Preschool; Drug Therapy, Combination; Female; Hematologic Diseases; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Infant; Invasive Fungal Infections; Male; Mycoses; Retrospective Studies; Survival Analysis; Transplantation, Homologous; Treatment Outcome; Voriconazole	2019
Why do lung transplant patients discontinue triazole prophylaxis? Transplant infectious disease : an official journal of the Transplantation Society, 2019, Volume: 21, Issue:3 Topics: Adult; Aged; Antifungal Agents; Drug Interactions; Female; Humans; Invasive Fungal Infections; Itraconazole; Lung Transplantation; Male; Medication Adherence; Middle Aged; Mycoses; Retrospective Studies; Triazoles; Voriconazole	2019
Comparative evaluation of isavuconazonium sulfate, voriconazole, and posaconazole for the management of invasive fungal infections in an academic medical center. Annals of clinical microbiology and antimicrobials, 2019, Mar-20, Volume: 18, Issue:1 Topics: Academic Medical Centers; Adult; Aged; Antifungal Agents; Female; Humans; Invasive Fungal Infections; Male; Middle Aged; Nitriles; Pyridines; Retrospective Studies; Triazoles; Voriconazole; Young Adult	2019
Invasive fungal consecutive infections in a patient with acute myeloid leukaemia. Nigerian journal of clinical practice, 2019, Volume: 22, Issue:4 Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Female; Fever; Humans; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Mucormycosis; Neutropenia; Treatment Outcome; Voriconazole	2019
Model-based Voriconazole Dose Optimization in Chinese Adult Patients With Hematologic Malignancies. Clinical therapeutics, 2019, Volume: 41, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Area Under Curve; China; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Middle Aged; Models, Statistical; Prospective Studies; Voriconazole; Young Adult	2019
Frequency of the CYP2C1917 polymorphism in a Chilean population and its effect on voriconazole plasma concentration in immunocompromised children. Scientific reports, 2019, 06-20, Volume: 9, Issue:1* Topics: Antifungal Agents; Child; Child, Preschool; Chile; Cytochrome P-450 CYP2C19; Female; Humans; Immunocompromised Host; Invasive Fungal Infections; Male; Polymorphism, Genetic; Voriconazole	2019
Prevalence of voriconazole-resistant invasive aspergillosis and its impact on mortality in haematology patients. The Journal of antimicrobial chemotherapy, 2019, 09-01, Volume: 74, Issue:9 Topics: Aged; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Drug Therapy, Combination; Female; Fungal Proteins; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Male; Microbial Sensitivity Tests; Middle Aged; Mortality; Mutation; Prevalence; Prognosis; Retrospective Studies; Survival Analysis; Voriconazole	2019
The cost-effectiveness of isavuconazole compared to the standard of care in the treatment of patients with invasive fungal infection prior to differential pathogen diagnosis in the United Kingdom. Journal of medical economics, 2020, Volume: 23, Issue:1 Topics: Antifungal Agents; Cost-Benefit Analysis; Decision Trees; Diagnosis, Differential; Health Expenditures; Health Resources; Health Services; Hospitalization; Humans; Invasive Fungal Infections; Models, Economic; Nitriles; Prescription Fees; Pyridines; Quality-Adjusted Life Years; State Medicine; Survival Analysis; Triazoles; Uncertainty; United Kingdom; Voriconazole	2020
Impact of oral voriconazole during chemotherapy for acute myeloid leukemia and myelodysplastic syndrome: a Japanese nationwide retrospective cohort study. International journal of clinical oncology, 2019, Volume: 24, Issue:11 Topics: Administration, Intravenous; Administration, Oral; Aged; Antifungal Agents; Female; Hospital Mortality; Humans; Invasive Fungal Infections; Japan; Length of Stay; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Retrospective Studies; Voriconazole	2019
Impact of Triazole Therapeutic Drug Monitoring Availability and Timing. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Drug Monitoring; Female; Humans; Invasive Fungal Infections; Itraconazole; Male; Middle Aged; Retrospective Studies; Triazoles; Voriconazole; Young Adult	2019
Aerosolization of Second-generation Triazoles: In Vitro Evaluation and Application in Therapy of Invasive Airway Aspergillosis. Transplantation, 2019, Volume: 103, Issue:12 Topics: Administration, Inhalation; Adult; Aerosols; Antifungal Agents; Aspergillosis; Bronchoscopy; Feasibility Studies; Female; Humans; Invasive Fungal Infections; Lung Transplantation; Respiratory Tract Infections; Triazoles; Voriconazole	2019
[Histoplasmosis: the multiple sides of an uncommon disease]. Le infezioni in medicina, 2015, Volume: 23, Issue:1 Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Brazil; Deoxycholic Acid; Diagnosis, Differential; Drug Combinations; Female; Hepatitis B, Chronic; Hepatitis D, Chronic; Histoplasmosis; Homosexuality, Male; Humans; Immunocompromised Host; Invasive Fungal Infections; Italy; Male; Risk Factors; Thailand; Treatment Outcome; Voriconazole	2015
Breakthrough invasive fungal infection under the use of posaconazole and voriconazole. Journal of the Formosan Medical Association = Taiwan yi zhi, 2016, Volume: 115, Issue:5 Topics: Antifungal Agents; Colletotrichum; Drug Resistance, Multiple, Fungal; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Opportunistic Infections; Triazoles; Voriconazole	2016
Variability of Voriconazole Trough Levels in Haematological Patients: Influence of Comedications with cytochrome P450(CYP) Inhibitors and/or with CYP Inhibitors plus CYP Inducers. Basic & clinical pharmacology & toxicology, 2016, Volume: 118, Issue:6 Topics: Adult; Antifungal Agents; Antineoplastic Agents; Cytochrome P-450 Enzyme Inducers; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Italy; Male; Middle Aged; Practice Guidelines as Topic; Retrospective Studies; Treatment Outcome; Voriconazole	2016
Use of intravoxel incoherent motion diffusion-weighted MR imaging for assessment of treatment response to invasive fungal infection in the lung. European radiology, 2017, Volume: 27, Issue:1 Topics: Adult; Antifungal Agents; Caspofungin; Diffusion Magnetic Resonance Imaging; Echinocandins; Female; Humans; Image Interpretation, Computer-Assisted; Invasive Fungal Infections; Lipopeptides; Lung Diseases, Fungal; Male; Middle Aged; Motion; Observer Variation; Prognosis; Prospective Studies; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Treatment Outcome; Voriconazole; Young Adult	2017
Therapeutic drug monitoring and safety of intravenous voriconazole formulated with sulfobutylether β-cyclodextrin in haematological patients with renal impairment. Mycoses, 2016, Volume: 59, Issue:10 Topics: Administration, Intravenous; Adolescent; Adult; Antifungal Agents; Aspergillosis; beta-Cyclodextrins; Creatinine; Cytochrome P-450 CYP2C19; Drug Compounding; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Invasive Fungal Infections; Male; Middle Aged; Prospective Studies; Renal Insufficiency; Voriconazole; Young Adult	2016
Prophylactic administration of voriconazole with two different doses for invasive fungal infection in children and adolescents with acute myeloid leukemia. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2018, Volume: 51, Issue:2 Topics: Adolescent; Adult; Anti-Bacterial Agents; Antifungal Agents; Child; Child, Preschool; Drug Monitoring; Female; Humans; Infant; Infant, Newborn; Invasive Fungal Infections; Japan; Leukemia, Myeloid, Acute; Male; Neutropenia; Pneumonia, Bacterial; Pre-Exposure Prophylaxis; Retrospective Studies; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Voriconazole; Young Adult	2018
Optimization of voriconazole dosage regimen to improve the efficacy in patients with invasive fungal disease by pharmacokinetic/pharmacodynamic analysis. Fundamental & clinical pharmacology, 2016, Volume: 30, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Candida albicans; Cohort Studies; Dose-Response Relationship, Drug; Female; Humans; Invasive Fungal Infections; Male; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Treatment Outcome; Voriconazole; Young Adult	2016
Economic evaluation of azoles as primary prophylaxis for the prevention of invasive fungal infections in Spanish patients undergoing allogeneic haematopoietic stem cell transplant. Mycoses, 2017, Volume: 60, Issue:2 Topics: Adult; Antifungal Agents; Cost-Benefit Analysis; Decision Support Techniques; Fluconazole; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Itraconazole; Spain; Triazoles; Voriconazole	2017
Invasive infections due to Saprochaete and Geotrichum species: Report of 23 cases from the FungiScope Registry. Mycoses, 2017, Volume: 60, Issue:4 Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Echinocandins; Female; Fluconazole; Fungemia; Geotrichosis; Geotrichum; Humans; Immunocompromised Host; Invasive Fungal Infections; Lipopeptides; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Registries; Saccharomycetales; Voriconazole; Young Adult	2017
Impact of the CYP2C19 genotype on voriconazole exposure in adults with invasive fungal infections. Pharmacogenetics and genomics, 2017, Volume: 27, Issue:5 Topics: Adult; Aged; Antifungal Agents; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Female; Genotype; Humans; Invasive Fungal Infections; Logistic Models; Male; Middle Aged; Pharmacogenomic Variants; Polymorphism, Single Nucleotide; Prospective Studies; Voriconazole	2017